Prohost Biotech – Exclusive Biotech Research

Exclusive Market Insight

& Scientific analysis

  • Exclusive Posts
  • Industry Newsletters
  • Clinical Trials
  • Possible Takeovers
  • Technology of the Week
  • Stock Table
  • Therapeutic Vaccines
  • Development-Stage Firms
  • Genomics
  • Prohost Picks
  • And much more...
Menu
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • Prohost Letters
  • Login / Register
    • Login
    • Register
  • Contact Us
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • Prohost Letters
  • Login / Register
    • Login
    • Register
  • Contact Us

Vertex Pharmaceuticals and Type 1 Diabetes

May 31, 2022 0
Vertex Pharmaceuticals to Announce New Data on VX-880 Clinical Trial Vertex Pharmaceuticals (VRTX) announced three abstracts, including two oral presentations and one poster, detailing data on type 1 diabetes (T1D) and its Phase 1/2 trial of VX-880, a stem cell-derived, fully differentiated pancreatic islet cell replacement therapy. The Abstracts have been accepted for presentation during the American Diabetes Association 82nd …

An Important Reminder from Vir Biotechnology

Eisai and Biogen: Lecanemab for the Treament of Early Alzheimer’s...

Sunshine Biopharma’s New mRNA Therapeutics Killed Cancer Cells with Little...

Reata Pharmaceuticals Completed Rolling NDA Submission of Omaveloxolone for Friedreich’s...

Intellia Therapeutics Statement on Recent U.S. Patent and Trademark Office...

These Dangerous World Circumstances and the Prohost Portfolio

The FDA Authorized Emergency Use of Pfizer Paxlovid Pills Against...

The FDA Cleared the IND for Erasca Inc Product ERAS-801...

Takeda Pharmaceutical Product LIVTENCITY Granted Approval by the FDA

Intellia Therapeutics to Highlight Ex Vivo Genome Editing and CRISPR/Cas9...

No Evidence of Data Manipulation in Technical Paper Foundational to...

Gilead Sciences and Merck Initiate Phase 2 Study Evaluating Lenacapavir...

Reata Pharmaceuticals Announces Presentations Highlighting Clinical Data for Bardoxolone and...

The U.S. FDA Approved Oyster Point Pharma Inc Product TYRVAYA™ to...

Don’t Miss the Enanta Pharmaceuticals Virtual Conference on October 19th...

Can Excision BioTherapeutics Inc Cure HIV?!

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed...

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

Impacting News

Akero Therapeutics: Two Financing Transactions with Pfizer and Hercules Capital

June 27, 2022 0
Akero Therapeutics Financing Transactions Akero Therapeutics (AKRO) is one of the selected firms for the Prohost …

Health Canada Approved Amylyx Pharmaceuticals’ Product ALBRIOZA for Amyotrophic Lateral Sclerosis

June 23, 2022 0
The Great News from Amylyx Pharmaceuticals On Jun. 13, 2022, Amylyx Pharmaceuticals (AMLX) announced that Health …

Inflation and the Stock Market. ASCO: Different Data’s Presentations Promising to Defeat Solid Tumors

June 10, 2022 0
Inflation and the Stock Market Inflation, which we were told was but a temporary passing phenomenon, …

Bristol-Myers Squibb: Deucravacitinib Demonstrates Promising Results in Treating Systemic Lupus Erithematosus

June 2, 2022 0
Bristol-Myers Squibb Product Deucravacitinib Bristol-Myers Squibb (BMY) product deucravacitinib has demonstrated positive results from the Phase …

The US FDA Approved United Therapeutics Product Tyvaso DPI™ for PAH and ILD

May 27, 2022 0
United Therapeutics Approval for Tyvaso DPI™ The US FDA approved United Therapeutics (UTHR) product Tyvaso DPI™ …

Alnylam Pharmaceuticals: Positive New Results of Lumasiran in Advanced Primary Hyperoxaluria Type 1

May 25, 2022 0
Alnylam Pharmaceuticals Alnylam Pharmaceuticals (ALNY) led the translation of RNA interference (RNAi) into a new class …

Trick or Trade

Kite Pharma’s Yescarta® Approved by the EC for Adults with Relapsed or Refractory Follicular Lymphoma

June 29, 2022 0
Kite Pharma - A Gilead Company In The NEWS Gilead Sciences' (GILD) firm Kite Pharma, announced …

What’s Going on with the Clinical-Stage Biotech Firms. See Also: Promising News From Evotec SE

April 9, 2022 0
The Clinical Stage Biotech Firms   We have reasons to believe that some clinical-stage biotechnology firms, …

Our Most Pressing Need. See Also: Important, Recent News from Incyte & Eli Lilly and Halozyme

March 29, 2022 0
Our Most Pressing Need Our current, most pressing need is news that makes sense. Stock Market …

Our Plan as the Stock Market Continues to Plummet

February 17, 2022 2
The Stock Market Continues to Plummet Indeed, the Stock Market continues to decline, losing investors' profits. …

Devastated and Resurrected Good Biotech Firms: Theravance Biopharma

December 15, 2021 0
The Market Devastation and Resurrection of Good Biotech Firms Due to the market’s instability that we …

Agenus Strategic Decision to Withdraw the BLA for Balsitilimab

October 22, 2021 0
Agenus to Withdraw BLA for Balstilimab Agenus (AGEN) announced a strategic decision to withdraw its Biologics …

Today’s Highlights

Regeneron: The Completed Acquisition of Checkmate Pharmaceuticals is Excellent News Not Bad News

May 31, 2022 0
Regeneron Pharmaceuticals Acquisition of Checkmate Pharmaceuticals  Regeneron Pharmaceuticals (REGN) announced a successful acquisition of Checkmate Pharmaceuticals, …

Karyopharm Therapeutics: CHMP Recommended Approval of the Firm’s Product NEXPOVIO® for Multiple Melanoma in Europe.

May 20, 2022 0
Karyopharm Therapeutics  Karyopharm Therapeutics (KPTI) and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, announced …

Vertex Provided Successful Results of VX-880 for Type 1 Diabetes Then Placed the Product on Clinical Hold

May 2, 2022 0
A lot is happening while the Stock Market is tanking and is finally being considered a …

Amgen: Repatha Studies Showed Sustained Reduction in Low-Density Lipoprotein Cholesterol with No New Safety Findings

April 27, 2022 0
Amgen Repatha Studies Repatha is the Longest Studied PCSK9i Amgen (AMGN) announced top-line results from two …

Gilead Sciences: Remdesivir is the First and Only Approved Treatment for Pediatric Patients with COVID-19. See Also: Cassava Sciences

April 26, 2022 0
Gilead Sciences Receives sNDA from the FDA for Remdesivir for Pediatric Patients with COVID-19 Gilead Sciences …

Promising Agreement Between Jazz Pharmaceuticals and Werewolf Therapeutics

April 8, 2022 0
Jazz Pharmaceuticals and Werewolf Therapeutics Agreement Jazz Pharmaceuticals (JAZZ) and Werewolf Therapeutics (HOWL)

Prohost Letters

Bear Market. Bad Market. Unpredictable Market.

May 17, 2022 0
Prohost Comprehensive Letter #450 BEAR MARKET. BAD MARKET. UNPREDICTABLE MARKET. Stock market investors usually learn from …

Comprehensive Prohost Letter #449 – Reality

March 27, 2022 0
Comprehensive Prohost Letter Issues Reality The Best of words in informative texts are the smallest in …

Comprehensive Prohost Letter #448

December 22, 2021 0
Comprehensive Prohost Letter Issues Coronavirus Variant Omicron A lot has happened since the coronavirus variant Omicron …

Comprehensive Prohost Letter Issues

September 19, 2021 0
The Comprehensive Prohost Letter Issues The Comprehensive Prohost Letter Issues will constitute a chain of 7 …

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0
Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

Companies Behind the Biotechnology Revolution

July 12, 2021 0
Prohost Portfolio PLUS #7 Companies Behind The Biotechnology Revolution Without these firms, basic science discoveries in …

Search ProhostBiotech

Popular Links

Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)
  • Recent

ProhostBiotech Archive

Sign Up for Weekly Emails

Prohost Biotech – Exclusive Biotech Research Copyright © 2022.
© 2014 Prohost Biotech. All rights reserved.

Privacy Policy | Cancellation Policy | Forward Looking Statement